
Carolyn D. Britten, MD, chief, Division of Hematology Oncology, associate director, Clinical Investigations, at the Hollings Cancer Center, Medical University of South Carolina, discusses questions that remain in immunotherapy.

Your AI-Trained Oncology Knowledge Connection!


Published: September 15th 2015 | Updated: